Growth Outcomes and Relapse Risk in Pediatric Medulloblastoma Survivors with and Without Growth Hormone Therapy: A 23-Year Single-Center Cohort Study.

J Clin Med · 2026 · PMC13164372 · PMID 42123204

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

did not reach statistical significancep = 0.07so close (0.05 < p ≤ 0.1)

The difference between chronological age and bone age (CA–BA) tended to be greater in the treated GHD group (3.49 ± 0.21 years) than in the untreated GHD group (2.23 ± 0.19 years), although this difference did not reach statistical significance ( p = 0.07).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.